{"id":"df6fbc49-381e-5695-9ce3-59f4f4a176df","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-tamoxifen-4oh","predicate":"contributes_to_4_hydroxylation_of","statement":"CYP2D6 and other CYPs formed 4-hydroxytamoxifen through a smaller initial route.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"698c62a4-d645-5851-a95e-55a5b487b0ee","mechanism_event_label":"Parent-drug removal and active-metabolite formation can move differently.","subject":{"id":"10f7a103-d63d-5bf4-8384-c5e1308ce126","slug":"cyp2d6","display_name":"Human cytochrome P450 2D6","entity_type_key":"protein"},"object":{"id":"53989c4c-d006-5dfc-a11b-8ac4ba48161c","slug":"tamoxifen","display_name":"Tamoxifen","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"698c62a4-d645-5851-a95e-55a5b487b0ee","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-tamoxifen-4oh-event","event_type":"biochemical_relationship","label":"Parent-drug removal and active-metabolite formation can move differently.","description":"CYP2D6 and other CYPs formed 4-hydroxytamoxifen through a smaller initial route.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"acac079b-66bd-5db4-a827-39092d9c9dfe","slug":"4-hydroxytamoxifen","display_name":"4-Hydroxytamoxifen","entity_type_key":"small_molecule"},"role":"product","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"10f7a103-d63d-5bf4-8384-c5e1308ce126","slug":"cyp2d6","display_name":"Human cytochrome P450 2D6","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"53989c4c-d006-5dfc-a11b-8ac4ba48161c","slug":"tamoxifen","display_name":"Tamoxifen","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dim-research/15159443.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"0668ce2256915fc1d4e4a5d395c544cb453e9f2599fef68f2dd5edede4f42081\", \"start_char\": 0, \"end_char\": 1544, \"text_sha256\": \"0668ce2256915fc1d4e4a5d395c544cb453e9f2599fef68f2dd5edede4f42081\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Kinetic, inhibition and recombinant-enzyme pathway mapping","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Therapeutically relevant substrate concentrations","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Biochemical pathway identity; does not attribute the observed DIM interaction to any single CYP or prove clinical cancer outcomes.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dim","display_name":"3,3'-Diindolylmethane / DIM","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human liver microsomes and expressed CYPs","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Parent-drug removal and active-metabolite formation can move differently.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dim-p15159443] Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. (2004). https://pubmed.ncbi.nlm.nih.gov/15159443/ DOI: 10.1124/jpet.104.065607","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Sequential tamoxifen metabolism","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"6292f30a-c97b-58e6-87c1-b47477401de4","evidence_kind":"source_excerpt","locator":"Lines 1013-1024","start_line":1013,"end_line":1024,"excerpt":"### dim-tamoxifen-4oh\nCYP2D6 and other CYPs formed 4-hydroxytamoxifen through a smaller initial route.\nCondition category: normal\nnutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Parent-drug removal and active-metabolite formation can move differently.\norganism: Human liver microsomes and expressed CYPs\ntissue_or_cell_type: Sequential tamoxifen metabolism\nexperimental_model: Kinetic, inhibition and recombinant-enzyme pathway mapping\nlimitations: Biochemical pathway identity; does not attribute the observed DIM interaction to any single CYP or prove clinical cancer outcomes.\nexposure: Therapeutically relevant substrate concentrations\nevidence_span: {\"source_cache\": \"artifacts/dim-research/15159443.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"0668ce2256915fc1d4e4a5d395c544cb453e9f2599fef68f2dd5edede4f42081\", \"start_char\": 0, \"end_char\": 1544, \"text_sha256\": \"0668ce2256915fc1d4e4a5d395c544cb453e9f2599fef68f2dd5edede4f42081\"}\n[dim-p15159443] Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. (2004). https://pubmed.ncbi.nlm.nih.gov/15159443/ DOI: 10.1124/jpet.104.065607","model_system":"Kinetic, inhibition and recombinant-enzyme pathway mapping","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dim-p15159443] Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. (2004). https://pubmed.ncbi.nlm.nih.gov/15159443/ DOI: 10.1124/jpet.104.065607","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"b6d70682-97f9-5893-a03c-f9f88836033c","stable_key":"import-182336c6-ed36-5ec6-8a09-25c31096262e","title":"Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"31e14060de904976d2f5d439f2bc9c8a99a72d34626c562c78429025e050d404","revision_id":"611094c1-a9cf-5b9b-b255-ac70b571696a","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}